Joseph A C, Juma S, Niku S D
SCI Nurs. 1994 Dec;11(4):95-9.
Neurogenic bladders with detrusor sphincter dyssynergia (DSD) are common in persons with spinal cord injury and with multiple sclerosis. Treatment options such as sphincterotomy, urethral foley and suprapubic catheters are not without complications or failure; however, they are recommended for patients who are unable to do intermittent catheterization. An endourethral prosthesis for DSD has been developed for experimental use in the United States. We report one year results of the clinical trials with endourethral prostheses implanted in ten patients. Initial subjective and objective results show an 80% success rate. At present, preliminary data show that an endourethral prosthesis, which is simple to insert and has few complications, appears to offer an alternative to conventional treatment. A key to success is to prepare for changes in life style that impact the patient's quality of life. Both patient and staff education are necessary pre-operatively to achieve successful outcomes post-operatively.
患有逼尿肌括约肌协同失调（DSD）的神经源性膀胱在脊髓损伤患者和多发性硬化症患者中很常见。诸如括约肌切开术、尿道 Foley 导管和耻骨上导管等治疗选择并非没有并发症或失败风险；然而，对于无法进行间歇性导尿的患者，这些方法是被推荐的。一种用于 DSD 的尿道内假体已在美国开发用于实验。我们报告了将尿道内假体植入 10 名患者的临床试验一年结果。初步的主观和客观结果显示成功率为 80%。目前，初步数据表明，一种易于插入且并发症少的尿道内假体似乎为传统治疗提供了一种替代方案。成功的关键是为影响患者生活质量的生活方式改变做好准备。术前对患者和医护人员进行教育对于术后取得成功结果都是必要的。
